Court restricts abortion access across U.S. by blocking mailing of mifepristone
A U.S. court has restricted access to abortion by blocking the mailing of mifepristone, a drug used in medication abortions. The ruling impacts the availability of telehealth abortion services across the country. This decision marks a significant shift in reproductive health policy and could affect millions of women.
- ▪A U.S. court ruled against mailing mifepristone, a key drug used in medication abortions.
- ▪The decision limits access to telehealth abortion services nationwide.
- ▪Mifepristone is one of two drugs commonly used in non-surgical abortions.
- ▪The ruling challenges current FDA regulations on the drug's distribution.
- ▪This could have wide-reaching implications for reproductive rights in the United States.
Opening excerpt (first ~120 words) tap to expand
CommentsComments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments. We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Hindu — Top.
Discussion
0 commentsMore from The Hindu — Top
